Hurtukova D. Dear healthcare provider letter regarding update: important safety and compatibility information for Treanda^® (bendamustine HCl) injection (45 mg/0.5 mL or 180 mg/2 mL solution). North Wales, PA: Teva Pharmaceuticals USA; 2015 Sep 2. From the FDA website. Accessed 2015 Sep 15.